BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Lone Star Bio

  The Caris Precision Oncology Alliance Welcomes MUSC Hollings Cancer Center

  Caris Life Sciences® announced that MUSC Hollings Cancer Center has joined the Caris Precision Oncology Alliance™.

  February 28, 2024

   · 

  5 min read
• Pharm Country

  HUTCHMED Reports 2023 Full Year Results and Provides Business Updates

  HUTCHMED Limited, the innovative, commercial-stage biopharmaceutical company, reports its financial results for the year ended December 31, 2023 and provides updates on key clinical and commercial developments.

  February 28, 2024

   · 

  35 min read
• BioMidwest

  Celcuity to Participate in Cowen’s 44th Annual Health Care Conference

  Celcuity Inc., announced its participation in Cowen’s 44th Annual Health Care Conference to be held in Boston on March 4-6, 2024.

  February 28, 2024

   · 

  1 min read
• Pharm Country

  Krystal Biotech to Present at TD Cowen 44th Annual Health Care Conference

  Krystal Biotech, Inc. announced that the Company will participate in the TD Cowen 44th Annual Health Care Conference, which takes place in Boston on March 4-6.

  February 28, 2024

   · 

  1 min read
• Business

  Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results

  Mersana Therapeutics, Inc. provided a business update and reported financial results for the fourth quarter and full year ended December 31, 2023.

  February 28, 2024

   · 

  10 min read
• Genetown

  Foghorn Therapeutics to Participate in Cowen’s 44th Annual Health Care Conference

  Foghorn® Therapeutics Inc. announced that it will participate in Cowen’s 44th Annual Health Care Conference, which is taking place on March 4–6, 2024, at the Boston Marriott Copley Place in Boston, MA.

  February 28, 2024

   · 

  1 min read
• Business

  Madrigal Pharmaceuticals Appoints Mardi C. Dier as Chief Financial Officer

  Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis, announced that Mardi C. Dier has been appointed Chief Financial Officer.

  February 28, 2024

   · 

  3 min read
• Business

  Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates

  Editas Medicine, Inc., a clinical-stage genome editing company, reported financial results for the fourth quarter and full year 2023 and provided business updates.

  February 28, 2024

   · 

  10 min read
• Business

  Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates

  Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for rare diseases, today announced financial results for the full-year ended December 31, 2023.

  February 28, 2024

   · 

  18 min read
• Genetown

  Kymera Therapeutics to Participate in Upcoming March 2024 Investor Conferences

  Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation, announced that the Company will participate in fireside chats at the following upcoming investor events.

  February 28, 2024

   · 

  1 min read